Niagen Bioscience, Inc. - Common Stock (NAGE)

CUSIP: 171077407

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / Common Stock
Shares outstanding
79,963,455
Total 13F shares
12,769,825
Share change
+379,114
Total reported value
$41,630,918
Put/Call ratio
0%
Price per share
$3.26
Number of holders
59
Value change
+$1,194,498
Number of buys
22
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 171077407?
CUSIP 171077407 identifies NAGE - Niagen Bioscience, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NAGE - Niagen Bioscience, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock Finance, Inc.
13F
Company
3.1%
2,472,096
$10,655,000 31 Dec 2019
13F
VANGUARD GROUP INC
13F
Company
2.6%
2,088,810
$9,002,000 31 Dec 2019
13F
ICONIQ Capital, LLC
13F
Company
2.1%
1,707,317
$7,359,000 31 Dec 2019
13F
Tieton Capital Management, LLC
13F
Company
1.9%
1,547,127
$6,668,000 31 Dec 2019
13F
STATE STREET CORP
13F
Company
0.85%
682,298
$2,941,000 31 Dec 2019
13F
Uniplan Investment Counsel, Inc.
13F
Company
0.84%
675,104
$2,909,000 31 Dec 2019
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.62%
498,933
$2,150,000 31 Dec 2019
13F
NORTHERN TRUST CORP
13F
Company
0.58%
464,513
$2,002,000 31 Dec 2019
13F
Mercator Fund (Cayman Master) LP
13F
Company
0.39%
315,025
$1,358,000 31 Dec 2019
13F
Sycale Advisors (NY) LLC
13F
Company
0.39%
315,025
$1,358,000 31 Dec 2019
13F
J.P. Morgan Private Wealth Advisors LLC
13F
Company
0.35%
278,221
$1,199,000 31 Dec 2019
13F
UBS Group AG
13F
Company
0.3%
237,924
$1,025,000 31 Dec 2019
13F
Bank of New York Mellon Corp
13F
Company
0.17%
132,331
$570,000 31 Dec 2019
13F
Nuveen Asset Management, LLC
13F
Company
0.14%
109,095
$470,000 31 Dec 2019
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.13%
102,441
$442,000 31 Dec 2019
13F
Raymond James Financial Services Advisors, Inc.
13F
Company
0.12%
97,624
$421,000 31 Dec 2019
13F
ELEVATION POINT WEALTH PARTNERS, LLC
13F
Company
0.09%
68,541
$302,000 31 Dec 2019
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.09%
69,819
$301,000 31 Dec 2019
13F
Composition Wealth, LLC
13F
Company
0.08%
66,000
$284,000 31 Dec 2019
13F
MORGAN STANLEY
13F
Company
0.08%
64,897
$279,000 31 Dec 2019
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.07%
59,893
$258,000 31 Dec 2019
13F
RHUMBLINE ADVISERS
13F
Company
0.06%
47,884
$206,000 31 Dec 2019
13F
BARCLAYS PLC
13F
Company
0.05%
41,010
$177,000 31 Dec 2019
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.04%
35,307
$152,000 31 Dec 2019
13F
D.A. DAVIDSON & CO.
13F
Company
0.04%
35,000
$151,000 31 Dec 2019
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.04%
33,688
$145,000 31 Dec 2019
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.04%
32,021
$138,000 31 Dec 2019
13F
Private Advisor Group, LLC
13F
Company
0.04%
29,934
$129,000 31 Dec 2019
13F
Zebra Capital Management LLC
13F
Company
0.04%
28,719
$123,000 31 Dec 2019
13F
GROUP ONE TRADING LLC
13F
Company
0.03%
27,542
$119,000 31 Dec 2019
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.03%
26,199
$113,000 31 Dec 2019
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.03%
25,688
$111,000 31 Dec 2019
13F
Cetera Advisor Networks LLC
13F
Company
0.03%
25,000
$108,000 31 Dec 2019
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.03%
22,404
$97,000 31 Dec 2019
13F
North Star Investment Management Corp.
13F
Company
0.03%
22,167
$96,000 31 Dec 2019
13F
OneDigital Investment Advisors LLC
13F
Company
0.02%
16,500
$71,000 31 Dec 2019
13F
Leap Investments LP
13F
Company
0.02%
16,100
$69,000 31 Dec 2019
13F
SEGALL BRYANT & HAMILL, LLC
13F
Company
0.02%
15,500
$67,000 31 Dec 2019
13F
Snowden Capital Advisors LLC
13F
Company
0.02%
15,000
$64,650 31 Dec 2019
13F
DEUTSCHE BANK AG\
13F
Company
0.02%
14,826
$63,000 31 Dec 2019
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.02%
14,084
$61,000 31 Dec 2019
13F
JPMORGAN CHASE & CO
13F
Company
0.02%
12,932
$56,000 31 Dec 2019
13F
INSIGHT 2811, INC.
13F
Company
0.02%
12,090
$52,000 31 Dec 2019
13F
Sargent Investment Group, LLC
13F
Company
0.02%
12,000
$52,000 31 Dec 2019
13F
Granite Investment Partners, LLC
13F
Company
0.01%
11,743
$51,000 31 Dec 2019
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.01%
10,700
$46,000 31 Dec 2019
13F
MAI Capital Management
13F
Company
0.01%
10,667
$46,000 31 Dec 2019
13F
Legal & General Group Plc
13F
Company
0.01%
8,704
$38,000 31 Dec 2019
13F
CITIGROUP INC
13F
Company
0.01%
8,223
$35,000 31 Dec 2019
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.01%
8,095
$35,000 31 Dec 2019
13F

Institutional Holders of Niagen Bioscience, Inc. - Common Stock (NAGE) as of Q1 2020

As of 31 Mar 2020, Niagen Bioscience, Inc. - Common Stock (NAGE) was held by 59 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,769,825 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, ICONIQ Capital, LLC, Tieton Capital Management, LLC, Uniplan Investment Counsel, Inc., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Sycale Advisors (NY) LLC, and FIRST REPUBLIC INVESTMENT MANAGEMENT, INC.. This page lists 59 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders
63
Q1 2020 holders
59
Holder diff
-4
Investor Q4 2019 Shares Q1 2020 Shares Share Diff Share Chg % Q4 2019 Value $ Q1 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .